Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dividend Distribution
confidence 92%
filed 2026-08-26
Item 8.01
News Corporation is disclosing daily share repurchase activity under its authorized $1 billion repurchase program. The Item 8.01 disclosure reports specific buyback transactions (11.2M Class A shares and 50.8K Class B shares on 26 August 2026 for approximately $291.4M total consideration), which constitutes a return of capital to shareholders. Share repurchases are classified as dividend_distribution under the taxonomy as they represent distributions or returns of capital to security holders, distinct from operational or financial events.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-26
The filing discloses under Item 3.02 an unregistered sale of 5,421 common shares of beneficial interest for approximately $0.1 million at $23.06 per share, exempt under Section 4(a)(2) and Regulation D Rule 506. This is a private placement of equity securities. While the August issuance amount is modest, the filing indicates the Company is "currently offering Shares on a monthly basis" as part of a continuous private offering, signaling ongoing dilutive capital raising activity material to investors assessing ownership dilution and the fund's capital structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-26
Item 8.01
Summit disclosed positive Phase III clinical trial results for its partner Akeso's HARMONi-GI1 study of ivonescimab in advanced biliary tract cancer, achieving statistically significant overall survival superiority versus durvalumab plus chemotherapy. This represents a material operational/clinical milestone for Summit's lead investigational asset (SMT112/ivonescimab), supporting its ongoing regulatory pathway and commercial potential, though the trial was sponsored and conducted by Akeso rather than Summit directly. The event is operational rather than a specific earnings release, regulatory approval, or M&A activity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-26
Item 5.02
The filing discloses the appointment of Scott Reese as a director to Keysight's Board, effective August 26, 2026, following a Board-approved increase in size from 10 to 11 members. While the disclosure also mentions director compensation arrangements, the principal action is the appointment itself. Reese's extensive background in software, cloud platforms, and cybersecurity at major technology firms (GE Vernova, Autodesk) and his service on multiple public company boards makes this a material governance event affecting the composition and expertise of the Board.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-26
Item 3.01
CaliberCos received formal notice from Nasdaq on August 21, 2026, that its Class A common stock failed to meet the Minimum Bid Requirement (Nasdaq Listing Rule 5550(a)(2)) after closing below $1.00 per share for 33 consecutive business days. The company has been afforded a 180-calendar day grace period through February 17, 2027, to regain compliance. This is a classic delisting-risk disclosure under Item 3.01, with explicit acknowledgment that failure to cure could result in delisting and trading on OTC Markets.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-26
The 6-K body explicitly states that Exhibit 99.1 is "a copy of the press release of TORM plc, dated August 26, 2026, announcing the Company's interim results for the second quarter and half-year ended June 30, 2026." This is a discrete earnings announcement for interim (half-year) financial results, which qualifies as an earnings_release event rather than a periodic_interim report, since it is presented as a press release announcing results rather than the formal financial statements themselves.
View raw filing on EDGAR →
8-K
Going Concern
confidence 95%
filed 2026-08-26
Item 8.01
The auditor's report explicitly states "the Company has suffered recurring losses from operations that raise substantial doubt about its ability to continue as a going concern," and management's disclosure in Note 1 confirms "substantial doubt about the Company's ability to continue as a going concern within one year." The company has accumulated deficits of $32.0 million, net losses of $26.7 million in 2025, and expects continued operating losses. This is a material disclosure that would significantly affect a reasonable investor's assessment of the registrant's viability.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 45%
filed 2026-08-26
Item 8.01
The Company repurchased $10 million principal amount of its 1.50% Convertible Senior Notes due 2028 at 92.75% of par, with intent to cancel. While this is technically a debt retirement/reduction rather than issuance of new debt, it represents a material modification of the Company's direct financial obligations and capital structure. The transaction is material to investors assessing the registrant's leverage and financial position, though the classification is ambiguous—this could also fit `financial_other` as a debt retirement or refinancing activity not precisely captured by the taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-26
Item 5.07
This Item 5.07 disclosure reports the results of the Company's reconvened 2026 annual meeting of stockholders held on August 25, 2026, including voting outcomes on five proposals: election of two Class C directors, advisory compensation vote, auditor ratification, redomiciliation from Delaware to Texas, and transfer restrictions for NOL preservation. The filing presents detailed vote tallies for each matter, which is the core content of shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-26
Item 7.01
HPS Corporate Lending Fund declared regular and variable supplemental distributions to shareholders across multiple share classes, with per-share amounts ranging from $0.1813 to $0.1990 depending on class, payable on September 30, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-26
Item 3.02
HPS Corporate Capital Solutions Fund issued 872,284 common shares (121,953 Class I and 750,331 Class D) for total consideration of $23.73 million on August 1, 2026, pursuant to subscription agreements and exempt from Securities Act registration under Section 4(a)(2) and Regulations D/S.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-26
Item 7.01
The Fund declared regular distributions to shareholders across three share classes (Class I, D, and S Common Shares) with a gross per-share amount of $0.1390 (varying net amounts after fees), a record date of August 31, 2026, and a payment date of September 30, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-26
Item 5.02
The filing discloses both the departure of Brady Hayden as CFO and the appointment of Sean Piche as CFO, effective September 1, 2026. While both events occur, the principal focus and substantive disclosure centers on the appointment of Piche, including detailed background (30 years of finance experience, prior roles at EY, NBCUniversal, Viacom), his compensation package ($120,000–$180,000 base salary, 100% bonus, 150,000 RSUs), and his strategic role in the company's next growth phase. The departure is noted as non-contentious and receives minimal elaboration. This is material to investors as CFO transitions affect financial strategy and capital allocation at a company reporting record quarterly results.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-08-26
Item 7.01
The disclosure describes a share repurchase program authorized by the Board to repurchase up to $5.0 million of common stock, with 986,916 shares already repurchased as of August 25, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The program is material as it represents a significant capital allocation decision affecting shareholder value and outstanding share count.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-26
Item 8.01
The Board authorized a new $1.5 billion share repurchase program effective August 26, 2026, replacing the prior program with ~$11 million remaining. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" as stated in the taxonomy. The magnitude ($1.5 billion) and Board authorization make this material to investor assessment of capital allocation policy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-26
Item 2.02
Standard Nuclear issued a press release on August 26, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $4.7 million (an eight-fold increase from prior year), gross profit achievement for the first time, and significant backlog growth to $241.5 million. The filing explicitly states this is "the Company's first quarterly earnings report as a public company" and the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-08-26
Item 3.01
Kraft Heinz announced a voluntary transfer of its common stock listing from Nasdaq to the New York Stock Exchange, effective September 14, 2026. This is a strategic, planned transition to a major exchange rather than a delisting due to non-compliance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-08-26
Item 5.02
CPI Card Group appointed Brennan Hughes as Chief Accounting Officer effective August 24, 2026. Hughes brings 25+ years of finance and accounting leadership experience, including prior service as Chief Accounting Officer at Janus Henderson Group. The Compensation Committee approved comprehensive compensation arrangements including base salary of $350,000, short-term and long-term incentive targets of $200,000 each, a $100,000 restricted stock unit award, and a $150,000 sign-on bonus.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-26
Item 2.02
BeOne Medicines filed its 2026 Interim Report for the six months ended June 30, 2026 with the Shanghai Stock Exchange on August 26, 2026, and disclosed supplemental financial information including R&D expenses by product pipeline and reconciliation of key accounting differences between PRC GAAP and U.S. GAAP. While the primary report is filed in China, the 8-K Item 2.02 disclosure and Exhibit 99.1 furnish interim financial results and material accounting policy differences to U.S. investors, consistent with earnings_release classification for interim period financial disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-26
Item 1.01
Priority Technology Holdings, Inc. entered into and closed a Membership Interest Purchase Agreement on August 25, 2026, acquiring all membership interests of Convenient Payments, LLC (IntelliPay) for $11.5 million in cash plus up to $3.5 million in earnout payments. This is a material acquisition that establishes a new business segment (Priority Commerce Government) and is expected to contribute over $4 million in incremental revenue for the balance of 2026, clearly meeting the threshold for disclosure under Item 1.01 as a material definitive agreement and M&A activity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-26
Item 5.02
The filing discloses the appointment of Erica N. Truban as a director of F&M Bank Corp and its subsidiary Farmers & Merchants Bank, effective August 25, 2026. The principal action is a person taking a governance role. While the disclosure also mentions standard director compensation arrangements, the core event is the appointment itself, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-26
Item 3.01
Nasdaq notified American Resources Corporation on August 20, 2026 of non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its June 30, 2026 Form 10-Q. This is a classic delisting-risk disclosure under Item 3.01: the company has received formal notice of a continued listing rule violation and must submit a compliance plan by September 4, 2026 to avoid potential delisting. The company faces a deadline of October 15, 2026 to cure the delinquency, with the added complication that a prior March 10-Q filing remains outstanding.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-26
Item 2.02
Okta issued a press release on August 26, 2026 announcing financial results for the fiscal quarter ended July 31, 2026 (Q2 FY2027). The disclosure includes comprehensive quarterly financial metrics (revenue of $805 million, GAAP net income of $116 million, non-GAAP net income of $194 million), forward guidance for Q3 and full-year FY2027, and key operational metrics (RPO growth of 17% YoY, cRPO growth of 14% YoY). This is a standard quarterly earnings release attached as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-26
Item 2.02
Lantronix issued a press release disclosing financial results for fiscal fourth quarter and full year ended June 30, 2026, including Q4 revenue of $31.2M (8% YoY growth), full-year FY2026 revenue of $120.9M, GAAP EPS of ($0.10), non-GAAP EPS of $0.15, and Q1 FY2027 forward guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 85%
filed 2026-08-26
EX-99.1
This exhibit announces VersaBank's third quarter fiscal 2026 financial results and schedules a conference call to discuss those results on September 3, 2026. The disclosure states "Bank to Report Third Quarter Fiscal 2026 Results Thursday, September 3, 2026 at 7:00 a.m. ET" and includes details about the earnings call presentation by management. While the exhibit itself is technically an announcement of the upcoming earnings release rather than the results press release itself, it functions as the public notice of material quarterly financial results and is customarily classified as an earnings_release event in 6-K filings.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-26
Item 1.01
Serina Therapeutics entered into a Common Stock Purchase Agreement with Roth Principal Investments granting the Company the right to sell up to $25,000,000 of newly issued common stock over 36 months at the Company's discretion, subject to a 19.99% exchange cap. The unregistered sale of common stock relies on Section 4(a)(2) and Rule 506(b) exemptions and represents a dilutive equity issuance to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-26
Item 5.03
The filing discloses amendment of the certificate of incorporation to establish Series A-1 Convertible Preferred Stock in connection with closing of a private placement. While technically an Item 5.03 (bylaw/charter amendment), the material substance is the issuance of convertible preferred securities in a private placement, which is a dilutive capital raise. The reference to Item 1.01 of the prior 8-K (which typically covers material acquisitions and other transactions) and the explicit mention of "closing of its previously announced private placement" indicate this is a financing event, not a routine governance matter.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-26
Item 1.01
The filing discloses employment agreements with Brady Cobb (Interim CEO) and Michael Bondurant (Interim COO) that center on compensatory arrangements: base salaries ($300,000 and $275,000), performance-based cash bonuses tied to market capitalization milestones, option grants (231,250 and 200,000 respectively), and conditional RSU grants. While the agreements also formalize their executive appointments, the substantive disclosure focuses on the compensation structure and equity incentives, making this primarily a compensation event rather than a pure appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-08-26
Item 5.07
This Item 5.07 discloses the results of a stockholder action by written consent on August 25, 2026, in which a majority stockholder (First Finance, Ltd., holding 61.3% of voting power) approved two material issuances: (i) units with up to $15 million in gross proceeds that may result in 20%+ dilution, and (ii) advisor stock issuances that may also result in 20%+ dilution. The disclosure explicitly references Nasdaq Listing Rules 5635(c) and 5635(d), which govern shareholder approval of dilutive issuances. This is a shareholder vote result on material capital-raising and dilutive transactions.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-08-26
Item 1.01
Black Hawk Acquisition Corp issued a convertible promissory note with a principal amount of up to $300,000 to its Sponsor on August 21, 2026, bearing 10% annual interest with repayment triggered by a DeSPAC transaction or liquidation. The note is convertible into equity at $1.00 per share and was issued to fund working capital for the SPAC in its pre-combination phase.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-26
Item 3.02
Black Hawk Acquisition Corp issued an unregistered convertible note that may be converted into shares of common stock upon closing of a DeSPAC transaction, relying on Section 4(a)(2) exemption. This dilutive issuance materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-26
Item 1.01
This disclosure documents entry into a definitive merger agreement on August 22, 2026, whereby Starry Sea Acquisition Corp (SSEA), a SPAC, will merge with SuperiorMed Holdings Limited in a business combination. The agreement specifies the acquisition consideration ($200 million net value for SuperiorMed, payable in newly issued Purchaser Ordinary Shares at $10.00 per share), the merger structure (SPAC Merger followed by Acquisition Merger), board composition, and extensive closing conditions. This is a material acquisition transaction requiring shareholder approval and SEC registration statement approval, directly fitting Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-08-26
Item 8.01
The Trust filed a complaint in Massachusetts Superior Court against Anton Melchionda and Onyx Partners Ltd., LLC alleging fraud, unfair and deceptive conduct, and interference with business relationships related to a failed ~$947 million real estate transaction. The complaint alleges defendants misrepresented their funding capacity, induced the Trust into a purchase agreement, then engaged in a campaign to cloud title and block alternative sales, causing over $150 million in damages. This is material litigation involving a substantial financial claim directly affecting the Trust's core asset liquidation mission.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-26
Item 1.01
Biohaven's subsidiary BBIL entered into an exclusive worldwide license agreement with SK Biopharmaceuticals on August 26, 2026, granting SK rights to the Kv7 ion channel platform and lead candidate opakalim. The transaction includes $400 million in upfront cash ($350 million at closing, $50 million in 2027), up to $150 million in development and regulatory milestones, tiered royalties on net sales, and SK's assumption of $245 million in contingent obligations, representing a significant strategic disposition of intellectual property.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-26
Item 3.02
Stonepeak-Plus Infrastructure Fund LP sold approximately $44.9 million in unregistered limited partnership units to third-party investors on August 3, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-08-26
The filing announces an extraordinary shareholders' meeting decision to approve an extraordinary dividend distribution of COP 1,271 per share (totaling COP 1.2 trillion), payable September 1, 2026. This is a material capital distribution to shareholders funded by reallocation of a specific reserve, with clear ex-dividend dates and payment terms disclosed.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-26
Item 3.02
Carlyle Private Equity Partners Fund sold approximately $13.4 million in unregistered limited partnership units to investors on August 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions, resulting in dilution to existing unitholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-08-25
Item 8.01
The Board authorized on August 21, 2026 the repurchase of up to an additional 15 million shares, expanding the existing 15 million share authorization from January 2018 as a shareholder-value capital allocation action.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-25
Item 2.02
This is a clear earnings release disclosing Donaldson's quarterly and full-year fiscal 2026 financial results. The Item 2.02 filing explicitly states that "On August 26, 2026, Donaldson Company, Inc. issued a press release announcing its results of operations for the quarter and fiscal year ended July 31, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, segment performance, and forward guidance, all hallmarks of a standard earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-25
Item 2.02
HEICO Corporation issued a press release on August 25, 2026 announcing its results of operations for the three and nine months ended July 31, 2026, disclosing record net income (up 33%), record operating income (up 34%), and record net sales (up 23%). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-25
Item 2.02
The Marzetti Company issued a press release on August 25, 2026, announcing its results for the fourth quarter and fiscal year ended June 30, 2026. The disclosure includes consolidated net sales, gross profit, operating income, net income per diluted share, and full-year cash flows from operations—all core financial metrics. This is a standard earnings release attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-25
Item 2.02
Semtech announced financial results for Q2 fiscal 2027 (ended July 26, 2026), reporting record net sales of $341.9 million (up 17% sequentially and 33% year-over-year), GAAP diluted EPS of $1.59, adjusted diluted EPS of $0.71, and strong margin expansion with forward guidance for Q3 FY2027.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 88%
filed 2026-08-25
Item 5.02
Renasant Corporation announced the appointment of Catherine Mealor as Chief Financial Officer, effective January 1, 2027, with her joining the company on October 5, 2026 as Executive Vice President. The appointment includes detailed employment terms and compensation arrangements. James C. Mabry IV will retire as CFO effective December 31, 2026, and transition to an executive advisor role.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
Item 5.02
The disclosure centers on compensatory arrangements for named executives and directors: establishment of incentive compensation plan performance goals and target payments for fiscal 2027, grant of RSU awards to Messrs. Larsen, Voorhees, and Hochberg (67,023, 36,192, and 33,512 RSUs respectively), and approval of long-term incentive plan performance measures and target cash awards for fiscal 2027-2029 (ranging from $150,000 to $400,000 for executives). This is a classic Item 5.02(e) disclosure of compensatory arrangements affecting named executives and directors.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
Credit Acceptance completed a $600.0 million asset-backed non-recourse secured financing on August 20, 2026, issuing three classes of notes (A, B, and C) with interest rates ranging from 5.01% to 5.51%. The proceeds will be used to repay higher-cost outstanding indebtedness and for general corporate purposes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-25
Item 5.02
Aris Bolisay, Renesas's representative on Wolfspeed's Board of Directors, is resigning effective September 27, 2026. While the disclosure also mentions Renesas's appointment of a Board observer and retention of re-designation rights, the principal disclosed action is the departure of a director. The filing emphasizes the resignation and explicitly states the departure is not due to disagreement, suggesting a routine transition within a shareholder agreement framework.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-25
Item 2.02
Intuit disclosed financial results for fiscal year ended July 31, 2026, reporting full-year revenue of $21.4 billion (14% growth), GAAP operating income of $5.9 billion (20% growth), and GAAP EPS of $16.46 (20% growth), along with forward-looking guidance for fiscal 2027.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-25
Item 8.01
Intuit's Board approved a quarterly cash dividend of $1.38 per share, payable October 16, 2026, representing a 15% increase versus the prior year.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-25
Item 5.02
Robert A. Garechana was appointed as Chief Financial Officer, Executive Vice President, and Treasurer of Sun Communities, Inc., effective September 8, 2026, succeeding Fernando Castro-Caratini who transitions to an advisory role. The appointment includes a five-year employment agreement with a $625,000 base salary, 150% target bonus, and $2.5 million in restricted stock grants.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 1.01
Tractor Supply Company entered into an underwriting agreement on August 19, 2026, and issued $500 million in aggregate principal amount of 5.200% Senior Notes due 2032 on August 25, 2026, representing a material creation of a direct financial obligation.
View raw filing on EDGAR →